These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36570447)

  • 1. A practical guide to botulinum neurotoxin treatment of shoulder spasticity 2: Injection techniques, outcome measurement scales, and case studies.
    Wissel J; Camões-Barbosa A; Carda S; Hoad D; Jacinto J
    Front Neurol; 2022; 13():1022549. PubMed ID: 36570447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical guide to botulinum neurotoxin treatment of shoulder spasticity 1: Anatomy, physiology, and goal setting.
    Jacinto J; Camões-Barbosa A; Carda S; Hoad D; Wissel J
    Front Neurol; 2022; 13():1004629. PubMed ID: 36324373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shoulder Spasticity Treatment With Botulinum Toxin: A Nationwide Cross-Sectional Survey of Clinical Practices.
    Pinho S; Camões-Barbosa A; Hatia M; Moeda F; Melo X; Tocha J
    Cureus; 2023 Nov; 15(11):e48493. PubMed ID: 38073907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
    Mullins D; Winter A; Fini N; Dixon C; Aldous S; Palit M; Holland AE
    Disabil Rehabil; 2016 Sep; 38(19):1927-33. PubMed ID: 26714558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis.
    Andringa A; van de Port I; van Wegen E; Ket J; Meskers C; Kwakkel G
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1703-1725. PubMed ID: 30796921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S; Turner-Stokes L
    Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.
    Turner-Stokes L; Fheodoroff K; Jacinto J; Maisonobe P
    BMJ Open; 2013 Jun; 3(6):. PubMed ID: 23794582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE; Knutzen A; Kühl C; Möller B; Hellriegel H; Margraf NG; Deuschl G; Stolze H
    Brain Inj; 2017; 31(1):75-82. PubMed ID: 27880052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of a 15-years' experience in including shoulder muscles, when treating upper-limb spasticity post-stroke with botulinum toxin type A.
    Carvalho MP; Pinto D; Gorayeb M; Jacinto J
    Top Stroke Rehabil; 2018 Apr; 25(3):194-202. PubMed ID: 29322885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
    Fheodoroff K; Dressler D; Woldag H; Koßmehl P; Koch M; Maisonobe P; Reichel G
    Nervenarzt; 2019 Apr; 90(4):361-370. PubMed ID: 30324541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion.
    Lagnau P; Lo A; Sandarage R; Alter K; Picelli A; Wissel J; Verduzco-Gutierrez M; Suputtitada A; Munin MC; Carda S; Khan O; Koçer S; Reebye R
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L; Valls-Solé J; Garcia Pascual I; Maisonobe P;
    Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
    Simpson DM; Gracies JM; Yablon SA; Barbano R; Brashear A;
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice.
    Wissel J; Ri S
    Expert Rev Neurother; 2022 Jan; 22(1):27-42. PubMed ID: 34933648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.